MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation (Q39069521)
Jump to navigation
Jump to search
scientific article published on 28 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation |
scientific article published on 28 October 2013 |
Statements
1 reference
MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation (English)
1 reference
Jin Kyung Rho
1 reference
Yun Jung Choi
1 reference
Seon Ye Kim
1 reference
Tae Won Kim
1 reference
Eun Kyung Choi
1 reference
Seon-Joo Yoon
1 reference
Bu Man Park
1 reference
Eunhye Park
1 reference
Jong Hwan Bae
1 reference
Chang-Min Choi
1 reference
Jae Cheol Lee
1 reference
28 October 2013
1 reference
1 reference
1 reference
Identifiers
1 reference